Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

156.63
BATS BZX Real-Time Price
As of 1:46pm ET
 -0.25 / -0.16%
Today’s Change
86.00
Today|||52-Week Range
172.98
+36.27%
Year-to-Date
Salix Posts Wider-than-Expected Q4 Loss as Sales Slump - Analyst Blog
11:00am / Zacks.com
Jim Cramer Says Investors Should Buy Valeant Pharmaceuticals (VRX) After It Acquired ...
Feb 24 / TheStreet.com
What to Expect When Salix Pharmaceuticals (SLXP) Reports Fourth Quarter Earnings Toda...
Mar 02 / TheStreet.com
Valeant Pharma (VRX) Soars on Salix Buy: 3 Keys for Investors - Stocks in the News
Feb 23 / Zacks.com
3 Best Performing Stocks in February - Analyst Blog
Mar 02 / Zacks.com
Valeant shares surge 13% on Salix deal
Feb 23 / FT.com
Must Watch Stocks for Today
Mar 02 / Benzinga
Valeant/Salix: at what cost
Feb 23 / FT.com
Earnings Scheduled For March 2, 2015
Mar 02 / Benzinga
Why Valeant Pharmaceuticals Int'l Inc.'s Shares Took Off Today
Feb 23 / MotleyFool.com
Top 10 News for 2/23 - 2/27: Revised GDP Slips, but Beats, in Q4; Two Pharma Giants t...
Feb 27 / Investing Channel
Energy stocks retreat after crude declines
Feb 23 / FT.com
Whobs Next In The Pharma Buyout Boom?
Feb 26 / Investing Channel
Fed in Focus This Week - Ahead of Wall Street
Feb 23 / Zacks.com
Pharmacyclics considers $19bn sale
Feb 25 / FT.com
Valeant nears deal to buy Salix
Feb 21 / FT.com
Notable Downgrades: Rosetta Resources (ROSE), American Airlines (AAL), St. Jude Medic...
Feb 24 / Investing Channel
Oncolytics Biotech Completes Enrolment for Reolysin Study - Analyst Blog
Feb 19 / Zacks.com
Salix Pharmaceuticals (SLXP) Stock Price Target Increased Today at Cantor Fitzgerald
Feb 24 / TheStreet.com
Celsus Plunges on Dismal Dermatology Drug Study Results - Analyst Blog
Feb 18 / Zacks.com
Stock Market News for February 24, 2015 - Market News
Feb 24 / Zacks.com
Ignyta's Lead Drug Gets Orphan Status for Colorectal Cancer - Analyst Blog
Feb 18 / Zacks.com
Pharma ETFs in Focus on Valeant-Salix Deal - ETF News And Commentary
Feb 24 / Zacks.com
Pfizer NDA on Pain Management Candidate Accepted by FDA - Analyst Blog
Feb 17 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account